{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:56:58Z","timestamp":1791593818997,"version":"4.3.4"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.tmrv.2007.01.002","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:17:53Z","timestamp":1175167073000},"page":"S57-S107","source":"Crossref","is-referenced-by-count":100,"special_numbering":"S1","title":["Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions"],"prefix":"10.1016","volume":"21","author":[{"given":"Tom","family":"Feasby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Benstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2007.01.002_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib2","unstructured":"Chalmers Research Institute. IVIG systematic reviews. Unpublished"},{"key":"10.1016\/j.tmrv.2007.01.002_bib3","unstructured":"Feasby TE. Appropriateness of IVIG\u2014Hematology summaries. Unpublished"},{"key":"10.1016\/j.tmrv.2007.01.002_bib4","author":"Phillips"},{"key":"10.1016\/j.tmrv.2007.01.002_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1200\/JCO.1998.16.3.1226","article-title":"Progress of clinical oncology guidelines development using the practice guidelines development cycle: The role of practitioner feedback","volume":"16","author":"Browman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S0012162201220258","article-title":"Dramatic improvement of severe acute disseminated encephalomyelitis after treatment with intravenous immunoglobulin in a three-year-old boy","volume":"43","author":"Andersen","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0387-7604(99)00011-X","article-title":"A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment","volume":"21","author":"Apak","year":"1999","journal-title":"Brain Dev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.104.2.301","article-title":"Demyelinative brainstem encephalitis responsive to intravenous immunoglobulin therapy","volume":"104","author":"Assa","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2007.01.002_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0387-7604(99)00115-1","article-title":"Plasmapheresis in a child affected by acute disseminated encephalomyelitis","volume":"22","author":"Balestri","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0887-8994(00)00267-8","article-title":"Acute disseminated encephalomyelitis in autoimmune hemolytic anemia","volume":"24","author":"Jaing","year":"2001","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/088307389501000612","article-title":"Acute disseminated encephalomyelitis: Response to intravenous immunoglobulin","volume":"10","author":"Kleiman","year":"1995","journal-title":"J Child Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0887-8994(99)00042-9","article-title":"Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis","volume":"21","author":"Nishikawa","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(99)00072-6","article-title":"Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis","volume":"165","author":"Pradhan","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmrv.2007.01.002_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/08830738020170111001","article-title":"Outcome of severe encephalomyelitis in children: Effect of high-dose methylprednisolone and immunoglobulins","volume":"17","author":"Shahar","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0887-8994(00)00229-0","article-title":"Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins","volume":"24","author":"Straussberg","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.46.4.1173","article-title":"Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis","volume":"46","author":"Hahn","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/01.WNL.0000044051.79305.DD","article-title":"Multiphasic demyelinating disease involving central and peripheral nervous system in a child","volume":"60","author":"Mariotti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1468-1331.2001.00195.x","article-title":"Rapid clinical and CSF response to intravenous gamma globulin in acute disseminated encephalomyelitis","volume":"8","author":"Pittock","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/088307380001500614","article-title":"Recurrent acute disseminated encephalomyelitis associated with acute cytomegalovirus and Epstein-Barr virus infection","volume":"15","author":"Revel-Vilk","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib20","first-page":"258","article-title":"Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis","volume":"21","author":"Finsterer","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-510X(00)00379-8","article-title":"Treatment of Bickerstaff's brainstem encephalitis with immune globulin","volume":"178","author":"Fox","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmrv.2007.01.002_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00007836","article-title":"Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis","volume":"249","author":"Marchioni","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2169\/internalmedicine.42.191","article-title":"Neurologic complications associated with influenza vaccination: Two adult cases","volume":"42","author":"Nakamura","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.tmrv.2007.01.002_bib24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.54.6.1370","article-title":"Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin","volume":"54","author":"Sahlas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410270104","article-title":"Immune globulins promote remyelination in the CNS","volume":"27","author":"Rodriguez","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/jnnp.57.Suppl.69","article-title":"High dose immunoglobulin IV treatment in adrenoleukodystrophy","volume":"57","author":"Cappa","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02444000","article-title":"Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis","volume":"243","author":"Meucci","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archneur.1994.00540210031010","article-title":"Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy","volume":"51","author":"Dalakas","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1023096728131","article-title":"Brief report: A pilot open clinical trial of intravenous immunoglobulin in childhood autism","volume":"29","author":"DelGiudice-Asch","year":"1999","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.tmrv.2007.01.002_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","article-title":"Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics","volume":"26","author":"Gupta","year":"1996","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.tmrv.2007.01.002_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/088307389801300207","article-title":"Intravenous immunoglobulin treatment of children with autism","volume":"13","author":"Plioplys","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib32","first-page":"CD001797","article-title":"1. Cochrane Review: Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. (Download in two parts)","author":"Van Schaik","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.tmrv.2007.01.002_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIG in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF00868527","article-title":"A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"243","author":"Thompson","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double blind, placebo controlled study","volume":"56","author":"Vermeulen","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.40.2.209","article-title":"High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study","volume":"40","author":"Van Doom","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib40","first-page":"127","article-title":"The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy","volume":"51","author":"Kubori","year":"1999","journal-title":"No to Shinkei"},{"key":"10.1016\/j.tmrv.2007.01.002_bib41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s001340050471","article-title":"Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis","volume":"23","author":"Mohr","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tmrv.2007.01.002_bib42","first-page":"1494","article-title":"Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy","volume":"17","author":"Wijdicks","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tmrv.2007.01.002_bib43","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2007.01.002_bib44","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis\u2014Efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis\u2014Four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.tmrv.2007.01.002_bib46","unstructured":"Tsai MJ, Lai CC, Lin SC, et al. Intravenous immunoglobulin therapy in juvenile dermatomyositis. Zhonghua Min Guo Xiao Erke Yi Xue Hui Za Zhi 1997;38:111-5."},{"key":"10.1016\/j.tmrv.2007.01.002_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.61.1.37","article-title":"Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis","volume":"61","author":"Danieli","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tmrv.2007.01.002_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.57.Suppl.50","article-title":"Indications for intravenous gammaglobulin therapy in inflammatory myopathies","author":"Cherin","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib49","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: An open study in 11 adult patients","volume":"21","author":"Cherin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.59.5.758","article-title":"Demyelinating neuropathy in diabetes mellitus","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-002-0698-0","article-title":"Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP","volume":"249","author":"Cocito","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib53","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.1995.00540350039015","article-title":"Successful treatment of neuropathies in patients with diabetes mellitus","volume":"52","author":"Krendel","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0404.2003.02107.x","article-title":"Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy","volume":"107","author":"Zochodne","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.tmrv.2007.01.002_bib52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/jnnp.67.5.607","article-title":"Progressive polyradiculoneuropathy in diabetes: Correlation of variables and clinical outcome after immunotherapy","volume":"67","author":"Jaradeh","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr\u00e9 syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Diener","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.002_bib58","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2007.01.002_bib59","first-page":"68","article-title":"A randomized trial comparing intravenous immunoglobulin and plasmapheresis in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Nomura","year":"2001","journal-title":"Neurol Therapeut"},{"key":"10.1016\/j.tmrv.2007.01.002_bib60","first-page":"CD002063","article-title":"Systematic review: Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2003","journal-title":"Cochrane Database Syst Rev Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1744-9987.1998.tb00124.x","article-title":"Comparative study of efficacy of plasma exchange versus intravenous gammaglobulin treatment on acute postinfectious polyradiculoneuropathy: A preliminary report","volume":"2","author":"Hosokawa","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.tmrv.2007.01.002_bib62","first-page":"166","article-title":"Treatment of Guillain-Barr\u00e9 syndrome: Immunoglobulins or plasmapheresis?","volume":"134","author":"Martinez","year":"1998","journal-title":"Neurologia"},{"key":"10.1016\/j.tmrv.2007.01.002_bib63","first-page":"99","article-title":"Guillain-Barr\u00e9 syndrome (GBS): An appraisal","volume":"43","author":"El Zunni","year":"1997","journal-title":"Cent Afr J Med"},{"key":"10.1016\/j.tmrv.2007.01.002_bib64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00365549509019016","article-title":"Intravenous immunoglobulin treatment in children with Guillain-Barr\u00e9 syndrome","volume":"27","author":"Gurses","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.tmrv.2007.01.002_bib65","first-page":"CD001798","article-title":"1. Systematic review: Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Raphael","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(95)00357-8","article-title":"Sequential treatment of Guillain-Barr\u00e9 syndrome with extracorporeal elimination and intravenous immunoglobulin","volume":"137","author":"Haupt","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmrv.2007.01.002_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004150050005","article-title":"High-dose immunoglobulin therapy in sporadic inclusion body myositis: A double-blind, placebo-controlled study","volume":"247","author":"Walter","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib68","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIG: A double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib68a","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02592447","article-title":"Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind\/dose finding clinical study","volume":"24","author":"van Rijckevorsel-Harmant","year":"1994","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.tmrv.2007.01.002_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2008-1071468","article-title":"Intravenous immunoglobulin: A single blind trial in children with Lennox-Gastaut syndrome","volume":"21","author":"Illum","year":"1990","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.tmrv.2007.01.002_bib71","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.47.3.678","article-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"47","author":"Bain","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib72","first-page":"CD004429","article-title":"Intravenous immunoglobulin for multifocal motor neuropathy","author":"van Schaik","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/WNL.44.3_Part_1.429","article-title":"Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study","volume":"44","author":"Azulay","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib74","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study","volume":"124","author":"Leger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.tmrv.2007.01.002_bib76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.59.3.248","article-title":"Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study","volume":"59","author":"Van den Berg","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib77","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/135245850000602S06","article-title":"Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins\u2013interim results on drug safety of an ongoing study. IVIG study group","volume":"6","author":"Poehlau","year":"2000","journal-title":"Mult Scler"},{"key":"10.1016\/j.tmrv.2007.01.002_bib77a","article-title":"Prevention of relapse with intravenous immunoglobin study: Initial results of a dose-finding trial in relapsing-remitting multiple sclerosis","author":"Fazekas","year":"2006","journal-title":"European Neurological Society"},{"key":"10.1016\/j.tmrv.2007.01.002_bib78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1468-1331.2002.00501.x","article-title":"1. Meta analysis: Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: A meta-analysis","volume":"9","author":"Sorensen","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib79","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.50.2.398","article-title":"RRMS: Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses","volume":"50","author":"Achiron","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0140-6736(96)09377-4","article-title":"RRMS: Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group","volume":"349","author":"Fazekas","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.002_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1468-1331.2002.00500.x","article-title":"RRMS: No difference in efficacy of two different doses of intravenous immunoglobulins in MS: Clinical and MRI assessment","volume":"9","author":"Lewanska","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib82","first-page":"391","article-title":"Intravenous immunoglobulin treatment in relapsing-remitting multiple sclerosis: A double blind cross over study","volume":"4","author":"Oztekin","year":"1998","journal-title":"Mult Scler"},{"key":"10.1016\/j.tmrv.2007.01.002_bib83","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.50.5.1273","article-title":"RRMS: Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis","volume":"50","author":"Sorensen","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/cei.1996.104.s1.67","article-title":"Intravenous immune globulin in multiple sclerosis: Clinical and neuroradiological results and implications for possible mechanisms of action","volume":"104","author":"Achiron","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib85","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s002340000444","article-title":"RRMS: Qualitative and quantitative volumetric evaluation of the efficacy of intravenous immunoglobulin in multiple sclerosis: Preliminary report","volume":"42","author":"Teksam","year":"2000","journal-title":"Neuroradiology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib86","first-page":"1149","article-title":"Intravenous immunoglobulin in secondary progressive multiple sclerosis: Randomised placebo-controlled trial","volume":"364","author":"Hommes","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.tmrv.2007.01.002_bib87","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.55.8.1135","article-title":"IV immunoglobulin does not reverse established weakness in MS","volume":"55","author":"Noseworthy","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib88","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","article-title":"A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis","volume":"56","author":"Noseworthy","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib89","article-title":"Results of double-blind, randomised, placebo-controlled pilot study on the treatment of multiple sclerosis with intravenous immunoglobulin","volume":"3","author":"Poehlau","year":"1996","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib90","first-page":"CD002277","article-title":"1. Systematic review: Intravenous immunoglobulin for myasthenia gravis","author":"Gajdos","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib91","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib92","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1525-1594.2001.06717.x","article-title":"Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis","volume":"25","author":"Ronager","year":"2001","journal-title":"Artif Organs"},{"key":"10.1016\/j.tmrv.2007.01.002_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.10224","article-title":"Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis","volume":"26","author":"Wolfe","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tmrv.2007.01.002_bib94","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<551::AID-MUS14>3.0.CO;2-O","article-title":"Immunoglobulin treatment in refractory myasthenia gravis","volume":"23","author":"Achiron","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tmrv.2007.01.002_bib95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1991.tb04912.x","article-title":"Treatment of myasthenia gravis with high-dose intravenous immunoglobulin","volume":"84","author":"Cosi","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.tmrv.2007.01.002_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002826-200105000-00010","article-title":"The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis","volume":"24","author":"Hilkevich","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-0404.2003.00131.x","article-title":"Intravenous immunoglobulin in the preparation of thymectomy for myasthenia gravis","volume":"108","author":"Huang","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.tmrv.2007.01.002_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0303-8467(02)00017-3","article-title":"Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis","volume":"105","author":"Wegner","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.tmrv.2007.01.002_bib99","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1142::AID-MUS8>3.0.CO;2-8","article-title":"Hemolytic anemia associated with intravenous immunoglobulin","volume":"20","author":"Wilson","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tmrv.2007.01.002_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0887-8994(97)00136-7","article-title":"Juvenile myasthenia gravis: Treatment with immune globulin and thymectomy","volume":"18","author":"Herrmann","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib101","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0887-8994(99)00112-5","article-title":"High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis","volume":"22","author":"Selcen","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3476(99)70422-1","article-title":"Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis","volume":"134","author":"Tagher","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib103","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-8994(97)00174-4","article-title":"High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis","volume":"18","author":"Bassan","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib104","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.tmrv.2007.01.002_bib105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.46.2.583-a","article-title":"Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin","volume":"46","author":"Pless","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib106","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/mds.10283","article-title":"Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG","volume":"17","author":"Pranzatelli","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.tmrv.2007.01.002_bib107","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1651-2227.1992.tb12248.x","article-title":"High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome","volume":"81","author":"Sugie","year":"1992","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0887-8994(00)00227-7","article-title":"Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome","volume":"24","author":"Yiu","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib109","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1651-2227.1993.tb12672.x","article-title":"Opsoclonus polymyoclonia syndrome","volume":"82","author":"Penzien","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3476(95)70322-5","article-title":"Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G","volume":"127","author":"Petruzzi","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-3476(96)70217-2","article-title":"Immune globulin G for treatment of opsoclonus-polymyoclonus syndrome","volume":"129","author":"Eiris","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3476(96)70225-1","article-title":"Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus","volume":"129","author":"Borgna-Pignatti","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2007.01.002_bib113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0887-8994(94)90127-9","article-title":"Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome","volume":"10","author":"Fisher","year":"1994","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib115","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","article-title":"A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy","volume":"249","author":"Comi","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib114","first-page":"CD002827","article-title":"1. Cochrane review: Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","author":"Lunn","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2007.01.002_bib116","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","article-title":"A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy","volume":"40","author":"Dalakas","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.63.1.28","article-title":"A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group","volume":"63","author":"Mariette","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tmrv.2007.01.002_bib119","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","article-title":"POEMS syndrome","author":"Dispenzieri","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.tmrv.2007.01.002_bib122","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/BF00873980","article-title":"Poor response to intravenous immunoglobulin therapy in patients with Castleman's disease and the POEMS syndrome","volume":"243","author":"Huang","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib118","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.01.002_bib120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-510X(98)00107-5","article-title":"Rapidly deteriorating polyneuropathy associated with osteosclerotic myeloma responsive to intravenous immunoglobulin and radiotherapy","volume":"158","author":"Benito-Leon","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmrv.2007.01.002_bib121","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00873555","article-title":"Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome","volume":"242","author":"Henze","year":"1995","journal-title":"J Neurol"},{"key":"10.1016\/j.tmrv.2007.01.002_bib123","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","article-title":"Results and long-term follow up of intravenous immunoglobulin infusions in chronic, refractory polymyositis: An open study with thirty-five adult patients","volume":"46","author":"Cherin","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.tmrv.2007.01.002_bib124","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000099074.04539.E0","article-title":"Experience with immunomodulatory treatments in Rasmussen's encephalitis","volume":"61","author":"Granata","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/01.WNL.0000115393.67403.53","article-title":"Rasmussen encephalitis with active inflammation and delayed seizures onset","volume":"62","author":"Korn-Lubetzki","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib126","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mds.10131","article-title":"Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis","volume":"17","author":"Frucht","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.tmrv.2007.01.002_bib127","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1212\/WNL.56.2.248","article-title":"Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis","volume":"56","author":"Villani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib128","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/WNL.52.4.738","article-title":"Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy","volume":"52","author":"Leach","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2007.01.002_bib129","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779630700003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779630700003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T03:29:24Z","timestamp":1587439764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779630700003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":131,"alternative-id":["S088779630700003X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2007.01.002","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}